Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 866 entries
View as:

Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT03518047 Org: User:
Start: 07/19/18 End: 02/11/20 Due: 02/11/21

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05599984 Org: User:
Start: 12/05/22 End: 11/30/27 Due: 11/30/28

A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02897115 Org: User:
Start: 09/12/16 End: 12/21/17 Due: 12/21/18

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Phase: N/A Priority: Normal
NCT ID: NCT03518034 Org: User:
Start: 05/03/18 End: 01/19/23 Due: 01/19/24

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Phase: N/A Priority: Normal
NCT ID: NCT02247401 Org: User:
Start: 11/04/14 End: 08/01/16 Due: 08/01/17

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03738397 Org: User:
Start: 02/21/19 End: 12/09/20 Due: 12/09/21

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06548542 Org: User:
Start: 09/04/24 End: 08/31/28 Due: 08/31/29

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04686136 Org: User:
Start: 02/19/21 End: 10/08/25 Due: 10/08/26

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02015793 Org: User:
Start: 12/31/13 End: 02/28/15 Due: 02/28/16

Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06806293 Org: User:
Start: 02/10/25 End: 07/31/27 Due: 07/31/28

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06820463 Org: User:
Start: 04/24/25 End: 04/30/28 Due: 04/30/29

Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02534870 Org: User:
Start: 09/30/15 End: 09/30/15 Due: 09/30/16

A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Phase: N/A Priority: Normal
NCT ID: NCT02692703 Org: User:
Start: 04/22/16 End: 06/29/17 Due: 06/29/18

Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain

Phase: N/A Priority: Normal
NCT ID: NCT02143713 Org: User:
Start: 05/27/14 End: 05/23/17 Due: 05/23/18

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Phase: N/A Priority: Normal
NCT ID: NCT05407636 Org: User:
Start: 01/13/22 End: 11/30/26 Due: 11/30/27

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Phase: N/A Priority: Normal
NCT ID: NCT03145909 Org: User:
Start: 07/03/17 End: 11/27/18 Due: 11/27/19

This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02772601 Org: User:
Start: 09/15/16 End: 09/22/17 Due: 09/22/18

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05711394 Org: User:
Start: 05/01/23 End: 05/31/28 Due: 05/31/29

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT03844048 Org: User:
Start: 09/06/19 End: 02/28/26 Due: 02/28/27

A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

Phase: N/A Priority: Normal
NCT ID: NCT04214028 Org: User:
Start: 12/26/19 End: 08/01/24 Due: 08/01/25

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02755597 Org: User:
Start: 07/11/16 End: 08/15/22 Due: 08/15/23

A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)

Phase: N/A Priority: Normal
NCT ID: NCT03258814 Org: User:
Start: 12/08/17 End: 09/14/18 Due: 09/14/19

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

Phase: N/A Priority: Normal
NCT ID: NCT06880744 Org: User:
Start: 06/17/25 End: 09/30/28 Due: 09/30/29

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT07039110 Org: User:
Start: 09/30/25 End: 03/31/28 Due: 03/31/29

A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation

Phase: N/A Priority: Normal
NCT ID: NCT05652205 Org: User:
Start: 12/29/22 End: 09/30/25 Due: 09/30/26